Prior data suggest that a primary function of CD53 is in lymphocyte homing, whereas it is the resident, or intrahepatic, B-cells that are considered primarily to mediate NASH pathology (60, 67, 68, 69). Here, CD53 is linked to metabolic dysfunction-associated steatohepatitis.